[6] [10] [14] Hot Warren Buffett Stocks To Invest In 2021

Related FireEye Swoons, Recovers Amid Erroneous Conference Cancellation Benzinga's Top Initiations FireEye Leads the Security as a Service Transformation With Expansion of FireEye as a Service (GuruFocus)

FireEye Inc (NASDAQ: FEYE) shares are trading lower by $0.04 at $18.30 in Thursday's session. It has been in a tight trading range since March 23.

The lower end of the range was reached just three days ago when it reached $16.97. That was just below a number of lows that were in the $17.20-$17.39 area during the aforementioned time period.

Related Link: FireEye Swoons, Recovers Amid Erroneous Conference Cancellation

The top of the range stands at its March 23 high of $18.58. Today's rally has come up just shy of that level at $18.50.

Posted-In: Futures Technicals Commodities Intraday Update Markets Trading Ideas

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Hot Warren Buffett Stocks To Invest In 2021: Poage Bankshares, Inc.(PBSK)

Poage Bankshares, Inc., incorporated on February 8, 2011, is a holding company for Town Square Bank (Town Square). Town Square is a federal savings association. The Company operates in banking segment. Town Square’s business consists of accepting savings accounts, checking accounts and certificates of deposits from the general public and investing those deposits, together with funds generated from operations and borrowings, primarily in first lien one-to-four-family mortgage loans, commercial and multi-family real estate loans, commercial and industrial loans consumer loans, consisting primarily of automobile loans and home equity loans and lines of credit, and construction loans. Town Square purchases investment securities consisting of mortgage-backed securities issued by the United States Government agencies and government-sponsored enterprises, and obligations of state and political subdivisions. Town Square provides financial services to individuals, families and businesses, through its banking offices located in and around Ashland, Nicholasville and Mt. Sterling, Kentucky.

Lending Activities

Town Square’s principal lending activity is the origination of first lien one- to four-family residential mortgage loans, and commercial and multi-family real estate loans, consumer loans, consisting of automobile loans, home equity loans and lines of credit, and construction loans. Its consumer loans include new and used automobile and truck loans, recreational vehicle loans and personal loans. Town Square offers home equity loans and lines of credit secured by a first or second mortgage on residential property, such as principal dwelling and condominium. Its commercial business loans consist of regular lines of credit and revolving lines of credit to businesses to finance short-term working capital needs, such as accounts receivable and inventory. Town Square also originates commercial term loans to fund long-term borrowing needs, such as purchasing equipment, property improvement! s or other fixed asset needs. It originates commercial loans, including real estate and non-real estate loans on the basis of the borrower’s ability to make repayment from the cash flow of the borrower’s business or rental income produced by the property.

Town Square makes construction loans to individuals for the construction of their residences. It also makes construction loans for the construction of homes on speculation, which include pre-sold and spec homes. Its loan servicing includes collecting and remitting loan payments, accounting for principal and interest, contacting delinquent borrowers, supervising foreclosures and property dispositions in the event of un-remedied defaults, making insurance and tax payments on behalf of the borrowers and administering the loans. Its total loans are approximately $316.35 million.

Investment Activities

Town Square’s investments include securities issued by the United States Government and its agencies or government sponsored entities, including residential mortgage-backed securities, municipalities, school boards and fully insured certificates of deposit. Its total securities available for sale are approximately $63.39 million.

Sources of Funds

Deposits are Town Square’s primary source of funds for use in lending and investment activities. Town Square also uses borrowings, primarily Federal Home Loan Bank (FHLB)-Cincinnati advances to lengthen the maturities of liabilities for interest rate risk purposes and to manage the cost of funds. It also receives funds from scheduled loan payments, investment maturities, loan prepayments, retained earnings, income on earning assets and the sale of assets. Its deposits are generated from within its primary market area. It offers a range of deposit accounts, including statement savings accounts, negotiable order of withdrawal (NOW) accounts, business checking, certificates of deposit, money market accounts and retirement accounts. Its borrowings consist of! advances! from the Federal Home Loan Bank of Cincinnati. Town Square has total deposits of approximately $343.13 million.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Poage Bankshares (NASDAQ:PBSK) announced its earnings results on Monday. The savings and loans company reported $0.21 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The company had revenue of $5.39 million for the quarter. Poage Bankshares had a negative return on equity of 4.84% and a negative net margin of 14.32%.

  • [By Joseph Griffin]

    News coverage about Poage Bankshares (NASDAQ:PBSK) has been trending somewhat negative on Thursday, according to Accern. The research firm identifies positive and negative media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Poage Bankshares earned a daily sentiment score of -0.06 on Accern’s scale. Accern also assigned headlines about the savings and loans company an impact score of 47.5091086029881 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Hot Warren Buffett Stocks To Invest In 2021: NTT DOCOMO, Inc(DCM)

NTT DOCOMO, INC. provides mobile communications services in Japan. The company operates through three segments: Telecommunications Business, Smart Life Business, and Other Businesses. It offers voice, data, and other value-added services; international calling roaming, and public wireless LAN services; Office Link, a service that allows mobile phones to be used as internal lines; Business Mopera Anshin Manager, which enables the unified control of corporate mobile phones; and satellite cell phone services. The company also provides optical-fiber broadband and Internet access services; video and music distribution, electronic books, and other services through its dmarket portal; finance/payment, shopping, and other services; medical database relating to healthcare-related companies, including pharmaceutical companies; and authentication and information services to medical personnel. In addition, it offers mobile device protection services; online courses; in-vehicle information/communication platform and data connectivity services; M2M services; eSIMs; Docomo DriveNet Navi, a car navigation services; Docomo DriveNet Info, a service for supporting car life; and docomo M2M Platform, which enables centralized management of docomo lines and overseas telecommunications carriers’ lines. Further, the company sells music software; operates cooking school, and content and content management platform; develops, sells, and maintains IT systems; offers mobile content delivery platform, billing/payment, cable television, and fixed telephone services; and is involved in the mail order sales of ingredients and cooking utensils. Additionally, it sells handsets and related equipment. The company sells its products through distributors and its stores, as well as through online. As of March 31, 2015, it had 2,399 docomo shops. The company was founded in 1991 and is headquartered in Tokyo, Japan. NTT DOCOMO, Inc. operates as a subsidiary of Nippon Telegraph and Telephone Corporation.

Advisors’ Opinion:

  • [By Shane Hupp]

    DATA Communications Management Corp (TSE:DCM) insider Michael Sifton purchased 12,500 shares of DATA Communications Management stock in a transaction that occurred on Wednesday, September 12th. The stock was bought at an average cost of C$1.52 per share, for a total transaction of C$19,000.00.

  • [By Joseph Griffin]

    Shares of NTT Docomo Inc (NYSE:DCM) have been given an average recommendation of “Hold” by the seven research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating and five have given a hold rating to the company.

  • [By Logan Wallace]

    Bank of Hawaii bought a new position in NTT Docomo Inc (NYSE:DCM) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,664 shares of the technology company’s stock, valued at approximately $222,000.

Hot Warren Buffett Stocks To Invest In 2021: Reading International Inc(RDI)

Reading International, Inc., a Nevada corporation (“RDI” and collectively with our consolidated subsidiaries and corporate predecessors, the “Company,” “Reading” and “we,” “us,” or “our”), was incorporated in 1999 incident to our reincorporation in Nevada. Our class A non-voting common stock (“Class A Stock”) and class B voting common stock (“Class B Stock”) are listed for trading on the NASDAQ Capital Market (Nasdaq-CM) under the symbols RDI and RDIB, respectively. Our principal executive offices are located at 6100 Center Drive, Suite 900, Los Angeles, California 90045. Our general telephone number is (213) 235-2240 and our website is www.readingrdi.com.   Advisors’ Opinion:

  • [By Stephan Byrd]

    RDI Reit (LON:RDI) had its price target upped by JPMorgan Chase & Co. from GBX 41 ($0.54) to GBX 205 ($2.68) in a report released on Wednesday. The firm currently has a neutral rating on the stock.

  • [By Shane Hupp]

    Peel Hunt restated their buy rating on shares of RDI Reit (LON:RDI) in a report published on Thursday.

    RDI stock opened at GBX 32.50 ($0.42) on Thursday. RDI Reit has a fifty-two week low of GBX 33.25 ($0.43) and a fifty-two week high of GBX 40.95 ($0.53).

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Reading International, Inc. Class A (RDI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Reading International (RDI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Warren Buffett Stocks To Invest In 2021: Zumiez Inc.(ZUMZ)

Zumiez Inc., including its wholly-owned subsidiaries, is a leading specialty retailer of apparel, footwear, accessories and hardgoods for young men and women who want to express their individuality through the fashion, music, art and culture of action sports, streetwear, and other unique lifestyles. Zumiez Inc. was formed in August 1978 and is a Washington State corporation.
At January 30, 2016, we operated 658 stores; 592 in the United States (“U.S.”), 42 in Canada and 24 in Europe. We operate under the names Zumiez and Blue Tomato. Additionally, we operate ecommerce websites at www.zumiez.com and www.blue-tomato.com.
We completed the acquisition of Snowboard Dachstein Tauern GmbH and Blue Tomato Graz Handel GmbH (collectively, “Blue Tomato”) during fiscal 2012. Blue Tomato is one of the leading European specialty retailers of apparel, footwear, accessories and hardgoods.
We employ a sales strategy that integrates our stores with our ecommerce platform.   Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    Zumiez (NASDAQ:ZUMZ)Q4 2018 Earnings Conference CallMarch 14, 2019, 5:00 p.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


  • [By Garrett Baldwin]

    STAKE YOUR CLAIM: Three pot stocks in particular could be poised for rare, wild gains of up to 1,000%. Click here to learn how you could see a $2 million “pot payday”…

    Shares of General Electric Co. (NYSE: GE) were up more than 1.1% despite news that the firm’s financial forecast fell well short of Wall Street expectations. The firm said that 2019 earnings will come in between $0.50 to $0.60 per share. That range is well below the $0.70 projected by Wall Street. CEO Larry Culp said that the firm’s current financial standing is “complex but clear” and said that it will rebound in 2020. Shares of Tailored Brands Inc. (NYSE: TLRD) plunged more than 20% after the owner of Joseph A. Bank fell well short of investors’ expectations. Although the firm beat earnings expectations, its 2019 outlook scared Wall Street. The firm expects a sharp decline in same-store sales. Look for other earnings reports from Broadcom Inc. (NASDAQ: AVGO), Jabil Inc. (NYSE: JBL), Noodles & Co. (NASDAQ: NDLS), Oracle Corp. (NASDAQ: ORCL), Tilly’s Inc. (NASDAQ: TLYS), Ulta Beauty Inc. (NASDAQ: ULTA), and Zumiez Inc. (NASDAQ: ZUMZ).
    This Could Be a HUGE Game Changer for Congress (and for You)

    We just held a live event with former Speaker of the House John Boehner and the most powerful people in the cannabis world for one important reason… to help you make a fortune from America’s most controversial, misunderstood, and lucrative industry. If you missed seeing this historic event LIVE – and John Boehner’s SHOCKING prediction – click here for a special rebroadcast.

Hot Warren Buffett Stocks To Invest In 2021: On Assignment Inc.(ASGN)

On Assignment, Inc., a diversified professional staffing firm, provides flexible and permanent staffing solutions in the United States, Europe, Canada, Australia, and New Zealand. The company?s Life Sciences segment provides contract and permanent life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, personal care, chemical, medical device, automotive, municipal, education, and environmental industries. Its contract professionals include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, biostatisticians, drug safety specialists, SAS programmers, medical writers, food scientists, regulatory affairs specialists, lab assistants, and other skilled scientific professionals. The company?s Healthcare segment offers locally-based and traveling contract professionals that include nurses, specialty nurses, respiratory therapists, surgical technicians, imaging technicians, X-ray technicians, medical technologists, medical assistants, pharmacists, pharmacy technicians, respiratory therapists, phlebotomists, coders, billers, claims processors, and collections staff, as well as dental professionals. This segment serves hospitals, integrated delivery systems, imaging centers, clinics, physician offices, reference laboratories, universities, managed care organizations, and third-party administrators. Its Physician segment provides short and long-term locum tenens services, and full-service physician search and consulting services. The company?s IT and Engineering segment offers high-end contract and direct placement services of information technology and engineering professionals with expertise in specialized information technology; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields. On Assignment, Inc. was founded in 1985 and is headquartered in Calabasas, Cali fornia.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Jefferies Financial Group started coverage on shares of ASGN (NYSE:ASGN) in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $70.00 target price on the business services provider’s stock.

  • [By Motley Fool Transcribing]

    On Assignment (NYSE:ASGN) Q4 2018 Earnings Conference CallFeb. 13, 2019 5:00 p.m. ET

    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:


Hot Warren Buffett Stocks To Invest In 2021: Rigel Pharmaceuticals Inc.(RIGL)

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases. Its product development programs include R788, which completed a phase 2 clinical trial for the treatment of rheumatoid arthritis; and is in phase 2 clinical trials for B-cell lymphoma, T-cell lymphoma, immune thrombocytopenia purpura, and certain solid tumors. The company?s product development programs also comprise R343, which is in phase 1b clinical trial for the treatment of asthma. In addition, its preclinical programs include oral JAK3 inhibitor program for research in the area of immunology/inflammation; adiponectin mimetics for the treatment of type 2 diabetes mellitus and other potential indications; and muscle atrophy program for muscle homeostasis. Further, the company is evaluating R763/AS703569 compound in its aurora kinase inhibition program targeting cancer cell proliferation. Rigel Pharmaceuticals, Inc. has collaboration agreements with AstraZeneca AB; Pfizer, Inc.; and Daiichi Pharmaceuticals Co., Ltd. The company was founded in 1996 and is based in South San Francisco, California.

Advisors’ Opinion:

  • [By Max Byerly]

    Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has been given a consensus rating of “Buy” by the ten analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $7.93.

  • [By Brian Orelli]

    Shares of Rigel Pharmaceuticals (NASDAQ:RIGL) jumped 20.9% in August, according to data provided by S&P Global Market Intelligence as investors in the biotech become more comfortable with the potential of Tavalisse, Rigel’s recently approved drug for chronic immune thrombocytopenia, which is characterized by low blood platelet levels.

Leave a Reply

Your email address will not be published. Required fields are marked *